Get the Stockscreener App
1.07
0.00%
0.00
Cardiol Therapeutics Inc stock is traded at $1.07, with a volume of 767.55K.
It is up +0.00% in the last 24 hours and down -5.31% over the past month.
Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's main product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.
See More
Previous Close:
$1.07
Open:
$1.06
24h Volume:
767.55K
Relative Volume:
1.08
Market Cap:
$89.57M
Revenue:
-
Net Income/Loss:
$-21.65M
P/E Ratio:
-3.2219
EPS:
-0.3321
Net Cash Flow:
$-15.84M
1W Performance:
-1.83%
1M Performance:
-5.31%
6M Performance:
-4.46%
1Y Performance:
-54.85%
1-Day Range:
$1.044
$1.09
1-Week Range:
$1.02
$1.138
52-Week Range:
$0.7709
$2.63
Cardiol Therapeutics Inc Stock (CRDL) Company Profile
Compare CRDL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CRDL
Cardiol Therapeutics Inc
|
1.07 | 91.27M | 0 | -21.65M | -15.84M | -0.3321 |
|
ZTS
Zoetis Inc
|
148.20 | 66.22B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.10 | 48.29B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.81 | 43.99B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
19.93 | 22.45B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
405.02 | 17.93B | 2.99B | 1.21B | 1.13B | 25.06 |
Cardiol Therapeutics Inc Stock (CRDL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-02-25 | Initiated | H.C. Wainwright | Buy |
| Jan-28-25 | Initiated | Rodman & Renshaw | Buy |
| Jun-26-24 | Initiated | ROTH MKM | Buy |
| Apr-22-24 | Initiated | H.C. Wainwright | Buy |
Cardiol Therapeutics Inc Stock (CRDL) Latest News
Cardiol Therapeutics (NASDAQ:CRDL) Shares Down 3.7%Here's What Happened - MarketBeat
Will Cardiol Therapeutics Inc. see short term momentum2025 Earnings Surprises & Proven Capital Preservation Methods - Newser
Will Cardiol Therapeutics Inc. stock go up soonJuly 2025 Technicals & Stepwise Entry/Exit Trade Alerts - Newser
Key resistance and support levels for Cardiol Therapeutics Inc.Earnings Overview Summary & Weekly Top Gainers Trade List - Newser
Cardiol Therapeutics Inc.’s volatility index tracking explainedJuly 2025 Sector Moves & Verified Short-Term Plans - Newser
Will Cardiol Therapeutics Inc. bounce back from current supportQuarterly Trade Report & Technical Entry and Exit Tips - Newser
What high frequency data says about Cardiol Therapeutics Inc.2025 Year in Review & Real-Time Stock Price Movement Reports - Newser
Is Cardiol Therapeutics Inc. stock ready for a breakoutJuly 2025 Outlook & Weekly Setup with High ROI Potential - Newser
Is Cardiol Therapeutics Inc. meeting your algorithmic filter criteriaJuly 2025 PostEarnings & Pattern Based Trade Signal System - Newser
Cardiol Therapeutics (TSE:CRDL) Trading Up 3.4%What's Next? - MarketBeat
What the charts say about Cardiol Therapeutics Inc. todayMarket Growth Summary & Stepwise Trade Execution Plans - Newser
Analyzing drawdowns of Cardiol Therapeutics Inc. with statistical toolsJuly 2025 Drop Watch & Comprehensive Market Scan Insights - Newser
Can momentum traders help lift Cardiol Therapeutics Inc.July 2025 Macro Moves & Capital Efficiency Focused Ideas - Newser
Using data models to predict Cardiol Therapeutics Inc. stock movementRate Cut & Technical Pattern Recognition Alerts - Newser
Risk adjusted return profile for Cardiol Therapeutics Inc. analyzedOptions Play & Low Drawdown Investment Ideas - Newser
Leading vs lagging indicators on Cardiol Therapeutics Inc. performance2025 Price Action Summary & Weekly Market Pulse Alerts - Newser
Cardiol Therapeutics (TSE:CRDL) Trading Up 3.4% – What’s Next? - Defense World
Should you hold or exit Cardiol Therapeutics Inc. nowPortfolio Gains Report & Real-Time Volume Spike Alerts - Newser
Analyzing Cardiol Therapeutics Inc. with multi timeframe charts2025 Volume Leaders & Free High Return Stock Watch Alerts - Newser
Will Cardiol Therapeutics Inc. benefit from macro trendsMarket Risk Analysis & AI Driven Price Predictions - Newser
Cardiol Therapeutics (NASDAQ:CRDL) Trading Down 3.7% – Here’s Why - Defense World
Visualizing Cardiol Therapeutics Inc. stock with heatmapsJuly 2025 Sentiment & Expert Verified Movement Alerts - Newser
How institutional ownership impacts Cardiol Therapeutics Inc. stockQuarterly Growth Report & Detailed Earnings Play Alerts - Newser
Should I buy Cardiol Therapeutics Inc. stock nowJuly 2025 News Drivers & High Accuracy Buy Signal Tips - beatles.ru
Can Cardiol Therapeutics Inc. outperform under higher oil pricesJuly 2025 Action & AI Optimized Trade Strategies - خودرو بانک
Detecting price anomalies in Cardiol Therapeutics Inc. with AIWeekly Trend Report & Risk Controlled Daily Trade Plans - Newser
A | What’s the outlook for Cardiol Therapeutics Inc.’s sectorGDP Growth & Free Fast Entry Momentum Trade Alerts - خودرو بانک
Cardiol Therapeutics Inc. stock trend forecastWeekly Investment Summary & Real-Time Market Sentiment Reports - Newser
Is Cardiol Therapeutics Inc. trending in predictive chart modelsWeekly Trading Summary & Risk Managed Investment Strategies - Newser
Is Cardiol Therapeutics Inc. stock a top performer YTDJuly 2025 News Drivers & Low Drawdown Trading Strategies - خودرو بانک
Tick level data insight on Cardiol Therapeutics Inc. volatilityJuly 2025 Recap & Expert Approved Momentum Trade Ideas - Newser
Cardiol Therapeutics Inc. stock daily chart insightsJuly 2025 Setups & Fast Entry High Yield Tips - Newser
Cardiol Therapeutics shares rise 4.59% premarket after Johnson & Johnson's new data highlights unmet needs in maternal fetal immunology. - AInvest
Is Cardiol Therapeutics Inc. forming a breakout patternJuly 2025 Spike Watch & Detailed Earnings Play Alerts - خودرو بانک
Understanding Cardiol Therapeutics Inc.’s price movementJuly 2025 Reactions & Free Growth Oriented Trading Recommendations - Newser
What’s the outlook for Cardiol Therapeutics Inc.’s sectorQuarterly Market Summary & Safe Entry Momentum Stock Tips - خودرو بانک
Is Cardiol Therapeutics Inc. in accumulation or distribution phaseJuly 2025 Intraday Action & Precise Swing Trade Alerts - خودرو بانک
Chart Watch: Can Cardiol Therapeutics Inc. be the next market leaderWeekly Investment Summary & Step-by-Step Swing Trade Plans - خودرو بانک
Is Cardiol Therapeutics Inc. forming higher highs and higher lowsMarket Risk Summary & Fast Entry and Exit Trade Plans - khodrobank.com
Price momentum metrics for Cardiol Therapeutics Inc. explainedJuly 2025 Review & Long Hold Capital Preservation Plans - Newser
Cardiol Therapeutics Inc Stock (CRDL) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.67%
0.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):